Red blood cell transfusion practice and cardiac comorbidities in patients with myelodysplastic syndromes
Patients with MDS frequently require RBC transfusion, and restrictive transfusion strategies predominate despite many patients having cardiac comorbidities. Further research is needed to address optimal transfusion strategies in such patients and associated cardiac outcomes.
Authors
- Allison Mo (ORCID: https://orcid.org/0000-0002-1923-3133)
- Erica M. Wood (ORCID: https://orcid.org/0000-0001-7527-2340)
- Jake Shortt (ORCID: https://orcid.org/0000-0003-3185-6488)
- Zoe McQuilten (ORCID: https://orcid.org/0000-0001-9698-7185)
Institutions
- Monash Health (AU)
- Alfred Health (AU)
- Austin Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Transfusion
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1111/trf.18391
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Sanofi
- Gilead Sciences
- CSL Behring
- Astex Pharmaceuticals
- National Blood Authority
- BeiGene
- Monash University
- Haematology Society of Australia and New Zealand
- Swedish Orphan Biovitrum
- Medical Research Council
- National Health and Medical Research Council
- Cilag